Genevac will preview its latest applications developments and innovative products for drug discovery and development at the forthcoming DDT 2006 exhibition in Boston, USA
In response to customer demand Genevac have developed a fast lyophilisation process to resolve problems that customers experience with HPLC solvents.
Using Genevac HT series evaporators, HPLC fractions can be concentrated to a few millilitres and then frozen and rapidly lyophilised to produce a diffuse dry powder, which can easily be re-dissolved or weighed out.
The new LyoSpeed facility allows the volatile organic solvent to be removed from the HT-Series evaporator condenser enabling the system to achieve the deep vacuums necessary to achieve good lyophilisation, without user intervention.
Genevac will show the second generation EZ-2 personal evaporator launched earlier this year.
The new EZ-2 further extends the benchmark performance, operational versatility and ease of use of its market-leading predecessor.
Incorporating state-of-the-art technology the EZ-2 is able to evaporate solvents in typically half the time of traditional evaporator designs.
Further time savings are made as users can see solvents as they collect in the trap and emptying the collection vessel is simple, requiring no defrosting.
Also on display will be the Genevac HT12 Series II system - an evaporator designed to provide the ideal solution for evaporation bottlenecks in the drug discovery laboratory.
The system's high performance and high sample capacities make them the ideal workhorses for the laboratory requiring high throughput evaporation.
The unique design of the multi layer rotor ensures efficient use of valuable laboratory bench space as well as high performance and high throughput evaporation.
